Ecolab Inc. ECL shares have gained 12.2% over the past three months, drawing attention to whether improving operating momentum can sustain the advance.
Faster growth in High-Tech, Digital and Life Sciences, firmer pricing and a higher 2026 earnings outlook support the case. Elevated debt, acquisition-related financing costs and macroeconomic uncertainty remain offsets.
Ecolab’s High-Tech Growth Strengthens the Bull Case
Global High-Tech organic sales rose 29% in the second quarter of 2026, while fixed-currency sales increased 139% with help from Ovivo Electronics. The platform is approaching $1.5 billion in annualized sales.
Management expects Global High-Tech, including Ovivo and CoolIT, to grow more than 25% annually and reach $4 billion in sales by 2030, with a 25% operating income margin. CoolIT also expands Ecolab’s data-center cooling capabilities.
ECL’s Digital and Life Sciences Engines Add Momentum
Ecolab Digital sales increased 27% in the second quarter, and management continues to target long-term growth above 20%. Connected monitoring and software broaden the company’s recurring technology opportunity across its installed base.
Global Life Sciences organic sales advanced 15%, while organic operating income surged 46% to $58.5 million. Share gains in bioprocessing and strength in pharmaceutical and personal-care applications added another faster-growing earnings stream.
Ecolab’s Pricing and Margins Support the Advance
Second-quarter organic sales increased 5%, supported by 4% pricing and 1% volume growth despite an approximately 1% headwind from Middle East customer disruptions. Organic operating margin expanded 40 basis points to 18.8%.
Management expects pricing of 5%-6% in the second half and an organic operating margin of about 20%. Productivity and One Ecolab savings should help offset higher commodity costs, although continued pricing execution remains important.
ECL’s Higher Debt Could Check Further Upside
Total debt climbed to $13.18 billion at the end of the second quarter from $8.49 billion at the end of the first quarter. Net interest expense rose to $73.1 million from $63.2 million a year earlier.
The CoolIT acquisition increases Ecolab’s data-center exposure but also raises financing and integration risk. Competitive pressure remains relevant as Pentair plc PNR operates across residential, commercial and industrial water solutions, while STERIS plc STE provides infection-prevention products and services to healthcare and life-sciences customers.

Image Source: Zacks Investment Research
Ecolab’s Outlook Tests Whether the Rally Can Continue
Ecolab raised its 2026 adjusted earnings guidance to $8.05-$8.25 per share, representing expected growth of 7%-10%. The company also projects 6%-7% organic sales growth in the second half.
Execution remains the key test. Geopolitical disruption, energy volatility, softer Heavy Water demand and pricing pressure could constrain results even as High-Tech and other growth engines gain scale.
ECL’s Cautious Rank Tempers the 12.2% Rally
The operating backdrop has improved, but the recent share-price gain now sits against higher leverage and near-term acquisition-related costs. That mix leaves the next phase of the rally dependent on continued sales growth and margin delivery.
Ecolab currently carries a Zacks Rank #4 (Sell). Its Momentum Score of A is the strongest Style Score, while the Value Score of F, Growth Score of C and VGM Score of D point to a less favorable value, growth and blended profile. Because Style Scores complement rather than override the Zacks Rank, the current setup remains cautious despite the stock’s recent momentum.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Research Chief Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.
Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Ecolab Inc. (ECL): Free Stock Analysis Report
Pentair plc (PNR): Free Stock Analysis Report
STERIS plc (STE): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research